Toleranzia is a research company focused on the development of drug candidates for the treatment of autoimmune diseases. The company has developed a platform technology focused on the muscular disease myasthenia gravis. In addition, the technology has been used in other areas such as diabetes and multiple sclerosis. Research collaboration is done together with external partners within the field. The head office is based in Gothenburg.

Quotes for Toleranzia AB

Right Now

+/-
0.19
%
4,58%
Latest
4.34
High
4.34
Low
4
Volume
23 315
Turnover (SEK)
96 427
Value (MSEK)
67,4

Board

CEO

  • Charlotte Fribert

Chairman Of The Board

  • Ola Rönn

Board

  • Anders Milton
  • Anders Waas
  • Eva Lindgren
  • Kristian Sandberg
  • Maarten Kraan

Videos

Upcoming reports

  • 2019-11-18 Delårsrapport 2019-Q3